APA (7th ed.) Citation

R, C., C, R., G, K., D, B., J, R., MY, M., . . . S, L. (2023). First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy. British journal of haematology, 201(5), 913. https://doi.org/10.1111/bjh.18733

Chicago Style (17th ed.) Citation

R, Chakraborty, Rosenbaum C, Kaur G, Bhutani D, Radhakrishnan J, Mapara MY, Maurer M, and Lentzsch S. "First Report of Outcomes in Patients with Stage IIIb AL Amyloidosis Treated with Dara-VCD Front-line Therapy." British Journal of Haematology 201, no. 5 (2023): 913. https://doi.org/10.1111/bjh.18733.

MLA (9th ed.) Citation

R, Chakraborty, et al. "First Report of Outcomes in Patients with Stage IIIb AL Amyloidosis Treated with Dara-VCD Front-line Therapy." British Journal of Haematology, vol. 201, no. 5, 2023, p. 913, https://doi.org/10.1111/bjh.18733.